Jupiter Neurosciences, Inc.
JUNS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001679628
No open-market purchases or sales by Jupiter Neurosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $826.9K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 13
- 13F valueReported value at the end of Q2 2026
- $826.9K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding JUNS, Q2 2026
No superinvestor reported holding JUNS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Jupiter Neurosciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Silva Alison D.Pres + Chief Business Officer | PPurchase | +750 | $1.03 | +$772.5 | +0.7%112.8K after | 3 lots |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Rosen ChristerCEO and Chairman | PPurchase | +3.60K | $1.02 | +$3.67K | 0.0%11.1M after | 2 lots |
| Jul 1, 2025 (view filing) | Jun 27-30 | 4 days | Silva Alison D.Pres + Chief Business Officer | PPurchase | +1.80K | $1.03 | +$1.86K | +1.6%112.0K after | 9 lots |
| Jul 1, 2025 (view filing) | Jun 27-30 | 4 days | Rosen ChristerCEO and Chairman | PPurchase | +7.82K | $1.02 | +$7.99K | +0.1%11.1M after | 7 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Jupiter Neurosciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vestor Capital, LLC | 2,193 | $557.0K | 0.03% | −968,792−99.8% | Reduced |
| Jane Street Group, LLC | 533,395 | $114.3K | 0.00% | +533,395 | New |
| Virtu Financial LLC | 231,240 | $50.0K | 0.00% | +217,665+1,603.4% | Added |
| Geode Capital Management, LLC | 156,127 | $33.4K | 0.00% | −55,569−26.2% | Reduced |
| Vanguard Capital Management LLC | 128,042 | $27.4K | 0.00% | −231,869−64.4% | Reduced |
| Vanguard Fiduciary Trust Co | 84,173 | $18.0K | 0.00% | −3,616−4.1% | Reduced |
| XTX Topco Ltd | 32,770 | $7.02K | 0.00% | +32,770 | New |
| Tower Research Capital LLC (TRC) | 28,786 | $6.17K | 0.00% | +28,786 | New |
| StoneX Group Inc. | 20,602 | $5.68K | 0.00% | +20,602 | New |
| Northern Trust Corp | 25,346 | $5.43K | 0.00% | 00.0% | Unchanged |